Ticagrelor-Induced Dyspnea
JACC: Cardiovascular Interventions · 2023
DOI: 10.1016/j.jcin.2023.09.009 ↗Kurz gefasst
Editorial in der Zeitschrift JACC: Cardiovascular Interventions, 2023. Verfasst von Gwangsil Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea; CPC Clinical Resea…. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Acute Coronary Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea; CPC Clinical Research, Aurora, Colorado, USA.
- CPC Clinical Research, Aurora, Colorado, USA; Cardiovascular Division, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Electronic address: cpcannon@bwh.harvard.edu.
Zitieren
APA
Kim, G., & Cannon, C. P. (2023). Ticagrelor-Induced Dyspnea. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2023.09.009
Vancouver
Kim G, Cannon CP. Ticagrelor-Induced Dyspnea. JACC: Cardiovascular Interventions. 2023. doi:10.1016/j.jcin.2023.09.009
BibTeX
@article{Kim2023,
author = {Kim, Gwangsil and Cannon, Christopher P},
title = {Ticagrelor-Induced Dyspnea},
journal = {JACC: Cardiovascular Interventions},
year = {2023},
doi = {10.1016/j.jcin.2023.09.009}
}
EUVIMED